Hepatocellular adenoma epidemiology and demographics

Hepatocellular adenoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatocellular adenoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatocellular adenoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatocellular adenoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatocellular adenoma epidemiology and demographics
CDC on Hepatocellular adenoma epidemiology and demographics
Hepatocellular adenoma epidemiology and demographics in the news
Blogs on Hepatocellular adenoma epidemiology and demographics
Directions to Hospitals Treating Hepatocellular adenoma
Risk calculators and risk factors for Hepatocellular adenoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

The incidence of hepatocellular adenoma is approximately 3 per 100,000 individuals worldwide. It is a rare benign tumor that is mainly found in women of child-bearing age.

Epidemiology and demographics

• The hepatocellular adenoma is more common in women in western countries, where they are exposed to higher doses of oral contraceptives.
• Hepatocellular adenoma is rare in regions where oral contraception is not widely used, such as asia.
• The prevalence of hepatocellular adenoma was increased in 1970s following the introduction of oral contraception in western countries.

Incidence

• The estimated incidence of hepatocellular adenoma is 3 per 1,000,000/year.
• The annual incidence is substantially higher with long term oral contraceptive use, estimated at 3 to 4 per 100,000, but may be less with newer oral contraceptives.

Age

• The hepatocellular adenoma is more common in woman of childbearing age who take oral contraceptives.

Gender

Women are more commonly affected with hepatocellular adenoma than males.

References

Template:WikiDoc Sources